Invitations: [Molecules-IF 4.927]-Special Issue “Natural Bio-Active Compounds with Pharmaceutical Applications” - With Discount

7 views
Skip to first unread message

Hamid Mukhtar

unread,
Apr 6, 2023, 3:32:40 AM4/6/23
to PUTF, Misbah Yaseen, Naveed Hussain, Layiba Mubeen, shazia erum, huss...@gcuf.edu.pk, Mazhar Hussain, hafi...@yahoo.com, Muhammad Akbar, Muhammad Asif Nawaz, Rukhama Haq, Yamin Bibi, Dr Khizer Hayat Bhatti, Sumaira Mehboob, Huma Muzammal, Iram Anjum, tahira kamal, Sobiya Shafique, Mohammad Saeed, Dr Muhammad Arshad, khajista jabeen, Nazim Hussain, snad...@yahoo.com, riz...@gcuf.edu.pk, Zafar Khalid, Neelma Munir, Laraib Meer, Asif Nadeem, Nadia Khan, Mehmood Jan, Maleeha Manzoor, Dr sheikh Ajaz Rasool, Nadir Rind, Saba Riaz, Waseem Haider, azra Yasmin, madiha nazir, Tahira Noor, Saad Farooq, mehbo...@pu.edu.pk, Hamid Rashid, saira ali, Hira Mubeen, javeria khalid, Irum Rao, nasim yasin, tehmina anjum, Sadia Saleem, Sara Junaid, mubbas...@gmail.com, FAISAL NOUROZ, Dr Muhammad Ishtiaq Ch, Maryam Suman, Dr. Hamid Mukhtar, waheed akram, Dr. Muhammad Anjum Zia, rizwan younis, mehwish iqtedar
Dear Colleagues
As-Salāmu `Alaykum (السلام عليكم)

I'm leading a Special Issue "Natural Bio-Active Compounds with Pharmaceutical Applications" in open access journal Molecules (IF 4.927, ISSN 1420-3049, https://www.mdpi.com/journal/molecules/about. It is my pleasure to invite you to submit *Review or Research articles* on this topic.

Submissions before 30 June 2023: 20% (460 CHF)discount.
Submissions before 31 August 2023: 10% (230 CHF) discount.

Special Issue website:

https://www.mdpi.com/journal/molecules/special_issues/M98P97XX52

If you accept this invitation, we would appreciate your response with a possible submission date and title. Looking forward to hearing from you soon. .
With kind regards,
DR. HAMID MUKHTAR
Professor of Biotechnology
Institute of Industrial Biotechnology,
GC University, Lahore-PAKISTAN
---------------------
Fulbright Scholar 2010-2011
Harvard Medical School, Boston, MA, USA
Reply all
Reply to author
Forward
0 new messages